
Opinion|Videos|December 21, 2023
Case 2: Male, 35 Years Old
Author(s)Elizabeth Kiracofe, MD, FAAD
Dr. Elizabeth Kiracofe discusses a case of unstable vitiligo in a 35-year-old male, addressing the impact of an outdoor lifestyle on treatment, the efficacy of topical ruxolitinib, and its utility in difficult-to-repigment areas.
Advertisement
Episodes in this series
Dr Elizabeth Kiracofe discusses a case of unstable vitiligo in a 35-year-old male, addressing the impact of an outdoor lifestyle on treatment, the efficacy of topical ruxolitinib, and its utility in difficult-to-repigment areas.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Dermalogica Enters Medical Aesthetics with FDA-Cleared Microneedling PRO Pen
2
Social Media Mythbusters: Hypochlorous Acid Sprays
3
Quoin Submits First-Ever IND Application for Peeling Skin Syndrome Therapy
4
SkinJect Advances into Registrable Development as Potential First-in-Class Therapy for Gorlin Syndrome
5











